Literature DB >> 17594950

New screening method for lung cancer by detecting volatile organic compounds in breath.

C Belda-Iniesta1, J de Castro Carpeño, J A Carrasco, V Moreno, E Casado Sáenz, J Feliu, M Sereno, F García Río, J Barriuso, M González Barón.   

Abstract

Lung cancer is a frequent cause of cancer-related deaths in the world. There is no valid screening process and this limits its detection to the late stages, with consequently high mortality rates. Volatile organic compounds (VOC) are chemical compounds (mainly the products of cell catabolism) found as gases in the human breath. Different methods have been developed to analyse VOCs and to compare them in healthy subjects and lung cancer patients. In this review, we summarise the different techniques used to analyse VOC. Many reports have been published with promising results similar to those achieved with accepted screening methods such as mammography. These methods show good perspectives on lung cancer screening.

Entities:  

Mesh:

Year:  2007        PMID: 17594950     DOI: 10.1007/s12094-007-0068-6

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.340


  27 in total

1.  Application of solid-phase microextraction and gas chromatography-mass spectrometry to the determination of volatile organic compounds in end-exhaled breath samples.

Authors:  C Prado; P Marín; J F Periago
Journal:  J Chromatogr A       Date:  2003-09-05       Impact factor: 4.759

2.  Lung cancer identification by the analysis of breath by means of an array of non-selective gas sensors.

Authors:  Corrado Di Natale; Antonella Macagnano; Eugenio Martinelli; Roberto Paolesse; Giuseppe D'Arcangelo; Claudio Roscioni; Alessandro Finazzi-Agrò; Arnaldo D'Amico
Journal:  Biosens Bioelectron       Date:  2003-09       Impact factor: 10.618

3.  Detection of lung cancer by sensor array analyses of exhaled breath.

Authors:  Roberto F Machado; Daniel Laskowski; Olivia Deffenderfer; Timothy Burch; Shuo Zheng; Peter J Mazzone; Tarek Mekhail; Constance Jennings; James K Stoller; Jacqueline Pyle; Jennifer Duncan; Raed A Dweik; Serpil C Erzurum
Journal:  Am J Respir Crit Care Med       Date:  2005-03-04       Impact factor: 21.405

Review 4.  Screening for lung cancer: New horizons?

Authors:  Antonio Rossi; Paolo Maione; Giuseppe Colantuoni; Filomena Del Gaizo; Ciro Guerriero; Dario Nicolella; Carmine Ferrara; Cesare Gridelli
Journal:  Crit Rev Oncol Hematol       Date:  2005-06-22       Impact factor: 6.312

5.  A computerized classification technique for screening for the presence of breath biomarkers in lung cancer.

Authors:  H J O'Neill; S M Gordon; M H O'Neill; R D Gibbons; J P Szidon
Journal:  Clin Chem       Date:  1988-08       Impact factor: 8.327

Review 6.  Role of oxidants/antioxidants in smoking-induced lung diseases.

Authors:  I Rahman; W MacNee
Journal:  Free Radic Biol Med       Date:  1996       Impact factor: 7.376

Review 7.  New developments in lung cancer screening.

Authors:  James L Mulshine
Journal:  J Clin Oncol       Date:  2005-05-10       Impact factor: 44.544

Review 8.  Cancer risk and oxidative DNA damage in man.

Authors:  S Loft; H E Poulsen
Journal:  J Mol Med (Berl)       Date:  1996-06       Impact factor: 4.599

9.  Detection of lung cancer with volatile markers in the breath.

Authors:  Michael Phillips; Renee N Cataneo; Andrew R C Cummin; Anthony J Gagliardi; Kevin Gleeson; Joel Greenberg; Roger A Maxfield; William N Rom
Journal:  Chest       Date:  2003-06       Impact factor: 9.410

Review 10.  Lung cancer screening with sputum cytologic examination, chest radiography, and computed tomography: an update for the U.S. Preventive Services Task Force.

Authors:  Linda L Humphrey; Steven Teutsch; Mark Johnson
Journal:  Ann Intern Med       Date:  2004-05-04       Impact factor: 25.391

View more
  3 in total

1.  Exhaled breath analysis: The new interface between medicine and engineering.

Authors:  Alquam Mashir; Raed A Dweik
Journal:  Adv Powder Technol       Date:  2009-09       Impact factor: 4.833

2.  Urinary volatile compounds as biomarkers for lung cancer: a proof of principle study using odor signatures in mouse models of lung cancer.

Authors:  Koichi Matsumura; Maryanne Opiekun; Hiroaki Oka; Anil Vachani; Steven M Albelda; Kunio Yamazaki; Gary K Beauchamp
Journal:  PLoS One       Date:  2010-01-27       Impact factor: 3.240

3.  Investigation of urinary volatile organic metabolites as potential cancer biomarkers by solid-phase microextraction in combination with gas chromatography-mass spectrometry.

Authors:  C L Silva; M Passos; J S Câmara
Journal:  Br J Cancer       Date:  2011-11-15       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.